Back to all news
ArronaxPlus confirms the city of Nantes' leadership in the field of nuclear medicine
05/01/2012
The ArronaxPlus project has been selected for funding under the second round of the Equipex infrastructure call for proposals (part of the French government's "Investing for the Future" program). The €8 million project notably aims at developing four hi-tech platforms for translational research in nuclear medicine.
This unique project reinforces Nantes' leadership in the field of radiopharmaceuticals. In the mid-term, this facility will boost existing international collaborations, increase France's competitiveness and raise the Atlanpole Biotherapies cluster's international profile in radiopharmaceuticals research.